Accuracy of Reports and Information. The Company is in compliance, to the extent applicable, with all reporting obligations under Section 12(g) of the Securities Exchange Act of 1934, as amended (the "EXCHANGE ACT"), except where the failure to so comply would not have a material adverse effect on the condition (financial or otherwise) or on the earnings, business affairs, properties or assets of the Company. The Company has registered its Common Stock pursuant to Section 12 of the Exchange Act and the Common Stock is admitted for quotation on the OTC Bulletin Board.
Appears in 2 contracts
Samples: Note Purchase Agreement (Neoprobe Corp), Note Purchase Agreement (Neoprobe Corp)
Accuracy of Reports and Information. The Company is in compliance, to the extent applicable, with all reporting obligations under Section 12(g) of the Securities Exchange Act of 1934, as amended (the "EXCHANGE ACT"“Exchange Act”), except where the failure to so comply would not have a material adverse effect on the condition (financial or otherwise) or on the earnings, business affairs, properties or assets of the Company. The Company has registered its Common Stock pursuant to Section 12 of the Exchange Act and the Common Stock is admitted for quotation on the OTC Bulletin Board.
Appears in 1 contract
